ANT-SM, adipose-derived stem cells for fecal incontinence
ANT-SM is autologous adipose-derived mesenchymal stem cells, that is not projected to evoke immune responses. In this study, ANT-SM are injected into the anal sphincter and patients are followed for 4 weeks to assess safety.
Read More
Product Information for
ANT-SM, adipose-derived stem cells for fecal incontinence
Links related to the product - may include a range of information sources (e.g., press releases, websites, patents) related to the specific cell therapy application.
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access
Access to this data is limited to
LifeMap Discovery Registered users onlySign in for full access